Uropathogenic Escherichia coli dominantly suppress the innate immune response of bladder epithelial cells by a lipopolysaccharide- and Toll-like receptor 4-independent pathway

Microbes and Infection

Volumn 10, Issue 2, 2008, Pages 114-121

  Hilbert, David W ^a   Pascal, Kristen E ^a   Libby, Erika K ^a   Mordechai, Eli ^a   Adelson, Martin E ^a   Trama, Jason P ^a  

^a Medical Diagnostic Laboratories LLC   (United States)

Author keywords

Escherichia coli; Toll like receptors; Urinary tract infections

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPROTEIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

AGONIST; ARTICLE; BACTERIUM ISOLATION; BLADDER EPITHELIUM; CONTROLLED STUDY; CYSTITIS; CYTOKINE RELEASE; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOREGULATION; INNATE IMMUNITY; PRIORITY JOURNAL; PYELONEPHRITIS; TOXICITY; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI;

CELL LINE; EPITHELIAL CELLS; ESCHERICHIA COLI; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA; URINARY BLADDER;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 39749087611     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2007.10.012     Document Type: Article

References (40)

1. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Disease-A-Month 49 (2003) 53-70
2. Bower J.M., Eto D.S., and Mulvey M.A. Covert operations of uropathogenic Escherichia coli within the urinary tract. Traffic (Copenhagen, Denmark) 6 (2005) 18-31
3. Graham J.C., and Galloway A. ACP Best Practice No 167: the laboratory diagnosis of urinary tract infection. Journal of Clinical Pathology 54 (2001) 911-919
4. Loane V. Obtaining urine for culture from non-potty-trained children. Paediatric Nursing 17 (2005) 39-42
5. Marrs C.F., Zhang L., and Foxman B. Escherichia coli mediated urinary tract infections: are there distinct uropathogenic E. coli (UPEC) pathotypes?. FEMS Microbiology Letters 252 (2005) 183-190
6. Martinez J.J., Mulvey M.A., Schilling J.D., Pinkner J.S., and Hultgren S.J. Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. EMBO Journal 19 (2000) 2803-2812
7. Mulvey M.A., Lopez-Boado Y.S., Wilson C.L., Roth R., Parks W.C., Heuser J., and Hultgren S.J. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science 282 (1998) 1494-1497
8. Anderson G.G., Palermo J.J., Schilling J.D., Roth R., Heuser J., and Hultgren S.J. Intracellular bacterial biofilm-like pods in urinary tract infections. Science 301 (2003) 105-107
9. Jantausch B.A., O'Donnell R., and Wiedermann B.L. Urinary interleukin-6 and interleukin-8 in children with urinary tract infection. Pediatric Nephrology (Berlin, Germany) 15 (2000) 236-240
10. Samuelsson P., Hang L., Wullt B., Irjala H., and Svanborg C. Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa. Infection and Immunity 72 (2004) 3179-3186
11. Schilling J.D., Martin S.M., Hunstad D.A., Patel K.P., Mulvey M.A., Justice S.S., Lorenz R.G., and Hultgren S.J. CD14- and Toll-like receptor-dependent activation of bladder epithelial cells by lipopolysaccharide and type 1 piliated Escherichia coli. Infection and Immunity 71 (2003) 1470-1480
12. Schilling J.D., Martin S.M., Hung C.S., Lorenz R.G., and Hultgren S.J. Toll-like receptor 4 on stromal and hematopoietic cells mediates innate resistance to uropathogenic Escherichia coli. Proceedings of the National Academy of Sciences of the United States of America 100 (2003) 4203-4208
13. Johnson J.R., Russo T.A., Scheutz F., Brown J.J., Zhang L., Palin K., Rode C., Bloch C., Marrs C.F., and Foxman B. Discovery of disseminated J96-like strains of uropathogenic Escherichia coli O4:H5 containing genes for both PapG(J96) (class I) and PrsG(J96) (class III) Gal(alpha1-4)Gal-binding adhesins. Journal of Infectious Diseases 175 (1997) 983-988
14. Gunther N.W.t., Lockatell V., Johnson D.E., and Mobley H.L. In vivo dynamics of type 1 fimbria regulation in uropathogenic Escherichia coli during experimental urinary tract infection. Infection and Immunity 69 (2001) 2838-2846
15. Kallenius G., Mollby R., and Winberg J. In vitro adhesion of uropathogenic Escherichia coli to human periurethral cells. Infection and Immunity 28 (1980) 972-980
16. Hunstad D.A., Justice S.S., Hung C.S., Lauer S.R., and Hultgren S.J. Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli. Infection and Immunity 73 (2005) 3999-4006
17. Pandey S., and Agrawal D.K. Immunobiology of Toll-like receptors: emerging trends. Immunology and Cell Biology 84 (2006) 333-341
18. Yoshimura A., Kaneko T., Kato Y., Golenbock D.T., and Hara Y. Lipopolysaccharides from periodontopathic bacteria Porphyromonas gingivalis and Capnocytophaga ochracea are antagonists for human toll-like receptor 4. Infection and Immunity 70 (2002) 218-225
19. Fichorova R.N., Cronin A.O., Lien E., Anderson D.J., and Ingalls R.R. Response to Neisseria gonorrhoeae by cervicovaginal epithelial cells occurs in the absence of toll-like receptor 4-mediated signaling. Journal of Immunology 168 (2002) 2424-2432
20. Hedges S., Agace W., Svensson M., Sjogren A.C., Ceska M., and Svanborg C. Uroepithelial cells are part of a mucosal cytokine network. Infection and Immunity 62 (1994) 2315-2321
21. Bergsten G., Samuelsson M., Wullt B., Leijonhufvud I., Fischer H., and Svanborg C. PapG-dependent adherence breaks mucosal inertia and triggers the innate host response. Journal of Infectious Diseases 189 (2001) 1734-1742
22. Frendeus B., Wachtler C., Hedlund M., Fischer H., Samuelsson P., Svensson M., and Svanborg C. Escherichia coli P fimbriae utilize the Toll-like receptor 4 pathway for cell activation. Molecular Microbiology 40 (2001) 37-51
23. Hedlund M., Wachtler C., Johansson E., Hang L., Somerville J.E., Darveau R.P., and Svanborg C. P fimbriae-dependent, lipopolysaccharide-independent activation of epithelial cytokine responses. Molecular Microbiology 33 (1999) 693-703
24. Hedlund M., Frendeus B., Wachtler C., Hang L., Fischer H., and Svanborg C. Type 1 fimbriae deliver an LPS- and TLR4-dependent activation signal to CD14-negative cells. Molecular Microbiology 39 (2001) 542-552
25. Hedges S., Svensson M., and Svanborg C. Interleukin-6 response of epithelial cell lines to bacterial stimulation in vitro. Infection and Immunity 60 (1992) 1295-1301
26. Schilling J.D., Mulvey M.A., Vincent C.D., Lorenz R.G., and Hultgren S.J. Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism. Journal of Immunology 166 (2001) 1148-1155
27. Agace W., Hedges S., Andersson U., Andersson J., Ceska M., and Svanborg C. Selective cytokine production by epithelial cells following exposure to Escherichia coli. Infection and Immunity 61 (1993) 602-609
28. Klumpp D.J., Weiser A.C., Sengupta S., Forrestal S.G., Batler R.A., and Schaeffer A.J. Uropathogenic Escherichia coli potentiates type 1 pilus-induced apoptosis by suppressing NF-kappaB. Infection and Immunity 69 (2001) 6689-6695
29. de Man P., van Kooten C., Aarden L., Engberg I., Linder H., and Svanborg Eden C. Interleukin-6 induced at mucosal surfaces by gram-negative bacterial infection. Infection and Immunity 57 (1989) 3383-3388
30. Zhang D., Zhang G., Hayden M.S., Greenblatt M.B., Bussey C., Flavell R.A., and Ghosh S. A toll-like receptor that prevents infection by uropathogenic bacteria. Science 303 (2004) 1522-1526
31. Hedges S., Anderson P., Lidin-Janson G., de Man P., and Svanborg C. Interleukin-6 response to deliberate colonization of the human urinary tract with gram-negative bacteria. Infection and Immunity 59 (1991) 421-427
32. Justice S.S., Hunstad D.A., Harper J.R., Duguay A.R., Pinkner J.S., Bann J., Frieden C., Silhavy T.J., and Hultgren S.J. Periplasmic peptidyl prolyl cis-trans isomerases are not essential for viability, but SurA is required for pilus biogenesis in Escherichia coli. Journal of Bacteriology 187 (2005) 7680-7686
33. Welch R.A., Burland V., Plunkett III G., Redford P., Roesch P., Rasko D., Buckles E.L., Liou S.R., Boutin A., Hackett J., Stroud D., Mayhew G.F., Rose D.J., Zhou S., Schwartz D.C., Perna N.T., Mobley H.L., Donnenberg M.S., and Blattner F.R. Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proceedings of the National Academy of Sciences of the United States of America 99 (2002) 17020-17024
34. Brzuszkiewicz E., Bruggemann H., Liesegang H., Emmerth M., Olschlager T., Nagy G., Albermann K., Wagner C., Buchrieser C., Emody L., Gottschalk G., Hacker J., and Dobrindt U. How to become a uropathogen: comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains. Proceedings of the National Academy of Sciences of the United States of America 103 (2006) 12879-12884
35. Lloyd A.L., Rasko D.A., and Mobley H.L. Defining genomic islands and uropathogen-specific genes in uropathogenic Escherichia coli. Journal of Bacteriology 189 (2007) 3532-3546
36. Libermann T.A., and Baltimore D. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Molecular and Cellular Biology 10 (1990) 2327-2334
37. Justice S.S., Hunstad D.A., Seed P.C., and Hultgren S.J. Filamentation by Escherichia coli subverts innate defenses during urinary tract infection. Proceedings of the National Academy of Sciences of the United States of America 103 (2006) 19884-19889
38. Ikaheimo R., Siitonen A., Heiskanen T., Karkkainen U., Kuosmanen P., Lipponen P., and Makela P.H. Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women. Clinical Infectious Diseases 22 (1996) 91-99
39. Russo T.A., Stapleton A., Wenderoth S., Hooton T.M., and Stamm W.E. Chromosomal restriction fragment length polymorphism analysis of Escherichia coli strains causing recurrent urinary tract infections in young women. Journal of Infectious Diseases 172 (1995) 440-445
40. Mysorekar I.U., and Hultgren S.J. Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract. Proceedings of the National Academy of Sciences of the United States of America 103 (2006) 14170-14175